Impact of Nivolumab versus Docetaxel on Health-Related Quality of Life and Symptoms in Patients with Advanced Squamous Non–Small Cell Lung Cancer: Results from the CheckMate 017 Study - Concepedia

Concepedia

Publication | Closed Access

Impact of Nivolumab versus Docetaxel on Health-Related Quality of Life and Symptoms in Patients with Advanced Squamous Non–Small Cell Lung Cancer: Results from the CheckMate 017 Study

106

Citations

26

References

2017

Year

Martin Reck, Fiona Taylor, John R. Penrod, Michael DeRosa, L Morrissey, Homa Dastani, Lucinda Orsini, Richard J. Gralla

Journal of Thoracic Oncology

Checkmate 017OncologyHealth-related QualityCancer ManagementOutcomes ResearchPatient-reported OutcomeCancer TreatmentMedicineLung Cancer

References

	Year	Citations

Page 1